CRISPR genome editing is revolutionizing medicine. Rapid market growth, fueled by startups and new therapies, brings ethical ...
UCSB Arts & Lectures and the Cancer Foundation of Santa Barbara host the Nobel Prize–winning biochemist for a talk on CRISPR ...
The first two days of the summit focused largely on somatic human genome editing, where the cells being altered are non-reproductive cells - as a result genetic changes cannot be passed on to future ...
This funding, provided through the NIH’s Somatic Cell Genome Editing Program, will support gene-editing research aimed at ...
Discover how genetic mutations, like BRCA1 and BRCA2, impact cancer risk and personalized treatment strategies.
In this interview, we spoke to Dr. Raquel Cuella Martin to learn about her research, her experiences working as an LGBTQIA+ researcher in STEMM and her advice for others beginning a STEMM career.
News Medical on MSN5d
Gene editing approach helps launch first-in-human clinical trial for rare genetic diseaseA collaborative effort between investigators at the National Institutes of Health's National Institute of Allergy and ...
The compact TnpB protein has previously been shown to work for genome editing in human cells, albeit with low efficiency and limited targeting ability due to its recognition requirements when ...
More information: Kim Fabiano Marquart et al, Effective genome editing with an enhanced ISDra2 TnpB system and deep ...
HuidaGene Therapeutics ("HuidaGene"), a global clinical-stage biotechnology company pioneering CRISPR-based programmable genome medicines, today announced the appointment of Dr. TJ Cradick as Chief ...
The compact TnpB protein has previously been shown to work for genome editing in human cells, albeit with low efficiency and limited targeting ability due to its recognition requirements when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback